Clinical Trial Update: A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of RCI001 ophthalmic solution versus placebo in dry eye disease; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• RCI001 Ophthalmic Solution (RCI001)

Snippet

Sponsor: ORA, Inc. | Conditions: Dry Eye Disease (DED) | Phase 2 | Status: NOT_YET_RECRUITING